Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2013-02-28
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses
NCT04908488
Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism
NCT01207466
Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT05933772
Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
NCT00584220
Performance Evaluation of Two Daily Disposable Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT04831515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Astigmatic Correction Lens
Nexis ACCL lenses vs commercial Toric Lenses
Astigmatic Correction Lens (Nexis ACCL lenses)
Astigmatic refractive error correction
Toric Soft Contact Lenses
commercial toric soft contact lenses
Toric Soft Contact Lenses
astigmatism correction using toric optics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Astigmatic Correction Lens (Nexis ACCL lenses)
Astigmatic refractive error correction
Toric Soft Contact Lenses
astigmatism correction using toric optics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18-65.
3. Patients able to understand the requirements of the study and willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements.
4. Best corrected visual acuity of 20/20 or better in the study eye/s
Exclusion Criteria
2. No previous corneal procedures, including Laser Vision Correction.
3. Any abnormalities associated with the eye lids.
4. Clinically significant inflammation or infection within six (6) months prior to study.
5. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator.
6. Participation in any study involving an investigational drug or device within the past 30 calendar days, or ongoing participation in a study with an investigational material except studies using corneal lenses.
7. Intolerance or hypersensitivity to topical anesthetics, fluorescein, or components of the material.
8. Specifically known intolerance or hypersensitivity to contact lenses.
9. Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FORSIGHT Vision3
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashley Tuan, OD, PhD
Role: PRINCIPAL_INVESTIGATOR
Nexisvision
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cliff Leong
Fremont, California, United States
Sara Chiu
Fremont, California, United States
John Michelsen
Livermore, California, United States
Nexis Vision
Menlo Park, California, United States
Nick Chan
San Mateo, California, United States
Josephine Vo-Laurel
Stockton, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.